Singapore markets closed

Aadi Bioscience, Inc. (AADI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.82000.0000 (0.00%)
As of 10:35AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 44.69M
Enterprise value -62.89M
Trailing P/E 1.89
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.01
Price/book (mrq)0.42
Enterprise value/revenue -2.58
Enterprise value/EBITDA 0.96

Trading information

Stock price history

Beta (5Y monthly) 0.30
52-week change 3-77.91%
S&P500 52-week change 321.61%
52-week high 38.6000
52-week low 31.5500
50-day moving average 32.0443
200-day moving average 33.8739

Share statistics

Avg vol (3-month) 3356.9k
Avg vol (10-day) 3194.22k
Shares outstanding 524.55M
Implied shares outstanding 624.55M
Float 816M
% held by insiders 112.45%
% held by institutions 152.85%
Shares short (28 Mar 2024) 4943.07k
Short ratio (28 Mar 2024) 41.53
Short % of float (28 Mar 2024) 45.84%
Short % of shares outstanding (28 Mar 2024) 43.84%
Shares short (prior month 29 Feb 2024) 4949.34k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 327 Aug 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -270.04%
Operating margin (ttm)-280.02%

Management effectiveness

Return on assets (ttm)-28.40%
Return on equity (ttm)-49.90%

Income statement

Revenue (ttm)24.35M
Revenue per share (ttm)0.90
Quarterly revenue growth (yoy)21.00%
Gross profit (ttm)N/A
EBITDA -71.76M
Net income avi to common (ttm)-65.77M
Diluted EPS (ttm)-2.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)108.84M
Total cash per share (mrq)4.43
Total debt (mrq)1.27M
Total debt/equity (mrq)1.20%
Current ratio (mrq)4.72
Book value per share (mrq)4.28

Cash flow statement

Operating cash flow (ttm)-59.66M
Levered free cash flow (ttm)-37.7M